Company logo

MDRX - Allscripts Healthcare Solutions, Inc.

NASDAQ -> Healthcare -> Health Information Services
Chicago, United States
Type: Equity

MDRX price evolution
MDRX
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $493.9 $501.47 $84.09 $190.52
Short term investments
Net receivables $262.44 $235.13 $244.86 $508.68
Inventory
Total current assets $810.77 $828.77 $1540.68 $761.34
Long term investments
Property, plant & equipment $26.23 $30.88 $26.07 $116.81
Goodwill & intangible assets $747.28 $755.9 $756.81 $1382.51
Total noncurrent assets $879.89 $885.45 $889.57 $1663.89
Total investments
Total assets $1690.66 $1714.22 $2430.26 $2425.23
Current liabilities
Accounts payable $12.61 $18.01 $15.55 $16.84
Deferred revenue $101.99 $86.9 $110.08 $330.31
Short long term debt $6.17 $6.09 $5.97 $19.6
Total current liabilities $253.09 $256.33 $646.86 $547.08
Long term debt $212.64 $213.77 $392.3 $414.88
Total noncurrent liabilities $260.55 $261.54 $430.29 $470.01
Total debt $218.81 $219.86 $398.27 $434.48
Total liabilities $513.64 $517.87 $1077.15 $1017.09
Shareholders' equity
Retained earnings $753.39 $738.86 $802.89 $767.56
Other shareholder equity -$3.89 -$3.93 -$3.1 -$2.77
Total shareholder equity $1177.02 $1196.35 $1353.11 $1408.14
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $190.52 $537.47 $137.54 $184.79
Short term investments
Net receivables $508.68 $497.75 $459.75 $465.26
Inventory
Total current assets $761.34 $1153.22 $841.26 $858.97
Long term investments $35.8 $43.81 $37.04
Property, plant & equipment $116.81 $168.76 $186.36 $121.91
Goodwill & intangible assets $1382.51 $1454.53 $1980.09 $2014.48
Total noncurrent assets $1663.89 $1764.4 $2364.48 $2322.52
Total investments
Total assets $2425.23 $2917.62 $3205.74 $3181.48
Current liabilities
Accounts payable $16.84 $35.91 $104.01 $73.17
Deferred revenue $330.31 $338.24 $392.18 $482.78
Short long term debt $19.6 $22.26 $387.6 $21.05
Total current liabilities $547.08 $934.78 $1210.69 $797.73
Long term debt $414.88 $261.05 $646.17 $648.31
Total noncurrent liabilities $470.01 $316.6 $709.86 $803.33
Total debt $434.48 $283.31 $1033.77 $669.36
Total liabilities $1017.09 $1251.38 $1920.55 $1601.06
Shareholders' equity
Retained earnings $767.56 $633.12 -$49.34 $132.84
Other shareholder equity -$2.77 -$1.84 -$4.39 -$5.39
Total shareholder equity $1408.14 $1666.24 $1285.19 $1551.11
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $151.92 $150.9 $142.67 $391.7
Cost of revenue $68.49 $71.42 $69.19 $222.71
Gross Profit $83.44 $79.48 $73.48 $168.99
Operating activities
Research & development $23.68 $22.75 $23.42 $47.74
Selling, general & administrative $32.52 $59.85 $41.32 $74.22
Total operating expenses $58.44 $84.84 $66.91 $127.61
Operating income $25 -$5.36 $6.57 $41.39
Income from continuing operations
EBIT $29.64 -$70.72 $10.57 $108.63
Income tax expense $13.87 -$8.58 -$14.42 $17.9
Interest expense $1.25 $1.89 $2.14 $3.46
Net income
Net income $14.53 -$64.03 $22.86 $87.28
Income (for common shares) $14.53 -$64.03 $22.86 $87.28
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $1503.04 $1502.7 $1771.68 $1749.96
Cost of revenue $883.47 $937 $1058.1 $1025.42
Gross Profit $619.57 $565.7 $713.58 $724.54
Operating activities
Research & development $193.67 $206.06 $254.51 $268.41
Selling, general & administrative $313.81 $389.94 $419.77 $450.97
Total operating expenses $534 $696.58 $738.04 $645.34
Operating income $85.57 -$130.88 -$24.46 $79.21
Income from continuing operations
EBIT $175.46 $717.82 -$162.92 $415.12
Income tax expense $27.85 -$16.69 -$23.91 $0.47
Interest expense $13.17 $34.1 $43.17 $50.91
Net income
Net income $134.44 $700.41 -$182.18 $363.74
Income (for common shares) $134.44 $700.41 -$182.18 $315.15
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income $14.53 -$64.03 $22.86 $87.28
Operating activities
Depreciation $13.81 $14.36 $14.1 $43.15
Business acquisitions & disposals $0.01 $671.4 -$23.02 $61.23
Stock-based compensation $4.55 $9.02 $6.32 $9.31
Total cash flows from operations $28.14 -$1.64 $69.26 $65.04
Investing activities
Capital expenditures -$8.17 -$9.96 -$9.95 -$18.53
Investments -$1.09 -$0.25
Total cash flows from investing -$9.25 $657.17 -$44.2 $42.7
Financing activities
Dividends paid
Sale and purchase of stock -$33.66 -$93.69 -$49.68 -$108.49
Net borrowings -$177.66 -$25
Total cash flows from financing -$38.45 -$285.95 -$62.97 -$133.55
Effect of exchange rate -$0.72 -$0.01 $0
Change in cash and equivalents -$19.57 $368.87 -$37.91 -$25.8
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income $134.44 $700.41 -$182.18 $363.74
Operating activities
Depreciation $176.14 $212.99 $229.64 $192.35
Business acquisitions & disposals $68.81 $1710 -$23.44 $630.53
Stock-based compensation $35.17 $34.04 $38.98 $34.64
Total cash flows from operations -$75.43 -$106.72 $46.25 $67.89
Investing activities
Capital expenditures -$78.56 -$105.02 -$130.44 -$144.62
Investments -$2.42 $17.87 -$7.19 -$16.93
Total cash flows from investing -$12.18 $1615.19 -$161.06 $248.01
Financing activities
Dividends paid
Sale and purchase of stock -$417.44 -$334.86 -$111.46 -$137.65
Net borrowings $172.6 -$768.86 $239.89 -$288.11
Total cash flows from financing -$258.87 -$1109.76 $67.34 -$292.98
Effect of exchange rate -$0.48 $1.21 $0.2 -$0.62
Change in cash and equivalents -$346.94 $399.93 -$47.26 $22.3
Fundamentals
Market cap $852.23M
Enterprise value $577.13M
Shares outstanding 109.26M
Revenue $837.19M
EBITDA $163.55M
EBIT $78.13M
Net Income $60.63M
Revenue Q/Q -58.86%
Revenue Y/Y -39.73%
P/E ratio 14.06
EV/Sales 0.69
EV/EBITDA 3.53
EV/EBIT 7.39
P/S ratio 1.02
P/B ratio 0.72
Book/Share 10.81
Cash/Share 4.52
EPS $0.55
ROA 2.94%
ROE 4.72%
Debt/Equity 0.72
Net debt/EBITDA 0.12
Current ratio 3.20
Quick ratio 3.20